Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 616 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR Dad Is Making Baby Giggle, But When He Makes A Sheep... May 21, 2019 EMA Recommends Extension of Indications for Atezolizumab September 28, 2020 A career forged in team science March 10, 2023 Neoadjuvant PD1/PD-L1 Blockade Combined with Chemotherapy Associated with High Resectability and... June 3, 2025 Load more HOT NEWS Teen Created App To Help His Non-Verbal Sister And Others Like... Cancer research in 2020: A spotlight on Manchester Sentinel Lymph Node Biopsy Navigated Neck Dissection Is Not Inferior to... Promising Results Observed with Front-line Sintilimab Plus a Bevacizumab Biosimilar in...
